Justin Thomas will have a new caddie on the bag at the Masters Tournament, but a familiar one to golf fans, as his full-time caddie Matt “Rev” Minister recovers from a recent back injury ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...

What if you could lose weight with a daily pill instead of painful weekly jabs like you would with Ozempic, the injectable form of semaglutide that controls both blood sugar and obesity? US ...

DEAR PEOPLE’S PHARMACY: I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from ...

Lenovo launched the Idea Tab Pro last month, positioning it in the mid-price segment. Where other brands were launching premium tablets above the Rs 1 lakh mark, Lenovo chose a different path and ...

This contrasts with the currently approved oral GLP-1 RA semaglutide (Rybelsus, Novo Nordisk), a peptide which ideally should be taken fasting and with no food or water for at least 30 minutes ...

At the 2-year, 3-year, and 4-year time points from the index date, those taking semaglutide had an increased risk for nonarteritic anterior ischemic optic neuropathy. HealthDay News — For patients ...

Introduction: Semaglutide (2.4 mg) and liraglutide (3.0 mg) are glucagon-like peptide-1 receptor agonist (GLP-1 RA) drugs used to promote weight loss, with evidence indicating a greater effect for ...

TUESDAY, April 15, 2025 (HealthDay News) — The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, ...